Terms: = Lung cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Prognosis
130 results:
1. Impact of Histone Lysine Methyltransferase SUV4-20H2 on cancer Onset and Progression with Therapeutic Potential.
Papadaki S; Piperi C
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473745
[TBL] [Abstract] [Full Text] [Related]
2. Hybrid epithelial-mesenchymal status of lung cancer dictates metastatic success through differential interaction with NK cells.
Parodi M; Centonze G; Murianni F; Orecchia P; Andriani F; Roato I; Gardelli C; Balsamo M; Moro M; Taiè G; Pastorino U; Petretto A; Lavarello C; Milione M; Sozzi G; Roz L; Vitale M; Bertolini G
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38458638
[TBL] [Abstract] [Full Text] [Related]
3. OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway.
Ci M; Zhao G; Li C; Liu R; Hu X; Pan J; Shen Y; Zhang G; Li Y; Zhang L; Liang P; Cui H
Cell Death Dis; 2024 Mar; 15(3):179. PubMed ID: 38429268
[TBL] [Abstract] [Full Text] [Related]
4. Diagnostic and prognostic value of serum soluble B7-H3 in nonsmall cell lung cancer.
Li Y; Xu L; Li J; Wang Q; Ma J
Anticancer Drugs; 2024 Jun; 35(5):426-432. PubMed ID: 38386015
[TBL] [Abstract] [Full Text] [Related]
5. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC.
Liu JS; Cai YX; He YZ; Xu J; Tian SF; Li ZQ
BMC Cancer; 2024 Jan; 24(1):123. PubMed ID: 38267913
[TBL] [Abstract] [Full Text] [Related]
6. Exposure to nickel chloride induces epigenetic modification on detoxification enzyme glutathione S-transferase M2.
Kang YT; Yang WJ; Huang HC; Tang SC; Ko JL
Environ Toxicol; 2024 Mar; 39(3):1729-1736. PubMed ID: 38050843
[TBL] [Abstract] [Full Text] [Related]
7. B7H3 targeting gold nanocage pH-sensitive conjugates for precise and synergistic chemo-photothermal therapy against NSCLC.
Chen B; Zheng K; Fang S; Huang K; Chu C; Zhuang J; Lin J; Li S; Yao H; Liu A; Liu G; Lin J; Lin X
J Nanobiotechnology; 2023 Oct; 21(1):378. PubMed ID: 37848956
[TBL] [Abstract] [Full Text] [Related]
8. THSD7A Positivity Predicts Poor Survival and Is Linked to High FAK Expression and fgfr1-Wildtype in Female Patients with Squamous Cell Carcinoma of the lung.
Flockerzi FA; Hohneck J; Langer F; Bohle RM; Stahl PR
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445817
[TBL] [Abstract] [Full Text] [Related]
9. Tumor-expressed B7-H3 promotes vasculogenic mimicry formation rather than angiogenesis in non-small cell lung cancer.
Fan X; Huang J; Hu B; Zhou J; Chen L
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8729-8741. PubMed ID: 37129607
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell lung cancer Patients Treated with Immune Checkpoint Inhibitors.
Genova C; Tasso R; Rosa A; Rossi G; Reverberi D; Fontana V; Marconi S; Croce M; Dal Bello MG; Dellepiane C; Tagliamento M; Ciferri MC; Zullo L; Fedeli A; Alama A; Cortese K; Gentili C; Cella E; Anselmi G; Mora M; Barletta G; Rijavec E; Grossi F; Pronzato P; Coco S
Cells; 2023 Mar; 12(6):. PubMed ID: 36980174
[TBL] [Abstract] [Full Text] [Related]
11. Comprehensive characterization of B7 family members in NSCLC and identification of its regulatory network.
Xiao M; Pang C; Xiang S; Zhao Y; Wu X; Li M; Du F; Chen Y; Wang F; Wen Q; Xiao Z; Yang Z; Shen J
Sci Rep; 2023 Mar; 13(1):4311. PubMed ID: 36922519
[TBL] [Abstract] [Full Text] [Related]
12. B7-H3/CD276 Inhibitors: Is There Room for the Treatment of Metastatic Non-Small Cell lung cancer?
Malapelle U; Parente P; Pepe F; Di Micco MC; Russo A; Clemente C; Graziano P; Rossi A
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555714
[TBL] [Abstract] [Full Text] [Related]
13. Expression and Clinical Significance of Various Checkpoint Molecules in Advanced Osteosarcoma: Possibilities for Novel Immunotherapy.
Xie L; Chen C; Liang X; Xu J; Sun X; Sun K; Yang R; Tang X; Guo W
Orthop Surg; 2023 Mar; 15(3):829-838. PubMed ID: 36519392
[TBL] [Abstract] [Full Text] [Related]
14. H3K27 acetylation activated-CCS regulates autophagy and apoptosis of lung cancer by alleviating oxidative stress.
Hu Y; Mu H; Deng Z
Tissue Cell; 2023 Feb; 80():101964. PubMed ID: 36402120
[TBL] [Abstract] [Full Text] [Related]
15. Clinicopathological features and prognostic impact of dirty necrosis in metastatic lung cancers from the colon and rectum.
Konishi Y; Taki T; Nakai T; Kuroe T; Morisue R; Miyoshi T; Tane K; Samejima J; Aokage K; Miyazaki S; Sakamoto N; Sakashita S; Watanabe R; Kojima M; Suzuki K; Tsuboi M; Ishii G
Cancer Sci; 2023 May; 114(5):2169-2177. PubMed ID: 36369892
[TBL] [Abstract] [Full Text] [Related]
16. Darinaparsin (ZIO-101) enhances the sensitivity of small-cell lung cancer to PARP inhibitors.
Cao GZ; Ma LY; Zhang ZH; Wang XL; Hua JH; Zhang JH; Lv Y; Zhang SB; Ou J; Lin WC
Acta Pharmacol Sin; 2023 Apr; 44(4):841-852. PubMed ID: 36253561
[TBL] [Abstract] [Full Text] [Related]
17. Enhanced CHOLESTEROL biosynthesis promotes breast cancer metastasis via modulating CCDC25 expression and neutrophil extracellular traps formation.
Tang Q; Liang B; Zhang L; Li X; Li H; Jing W; Jiang Y; Zhou F; Zhang J; Meng Y; Yang X; Yang H; Huang G; Zhao J
Sci Rep; 2022 Oct; 12(1):17350. PubMed ID: 36253427
[TBL] [Abstract] [Full Text] [Related]
18. Controversial role of mast cells in NSCLC tumor progression and angiogenesis.
Longo V; Catino A; Montrone M; Galetta D; Ribatti D
Thorac Cancer; 2022 Nov; 13(21):2929-2934. PubMed ID: 36196487
[TBL] [Abstract] [Full Text] [Related]
19. Methylation patterns of Lys9 and Lys27 on histone H3 correlate with patient outcome and tumor progression in lung cancer.
Zhang Y; Zheng B; Lou K; Xu X; Xu Y
Ann Diagn Pathol; 2022 Dec; 61():152045. PubMed ID: 36115104
[TBL] [Abstract] [Full Text] [Related]
20. B7-H3 is eligible for predicting clinical outcomes in lung adenocarcinoma patients treated with EGFR tyrosine kinase inhibitors.
Yang Y; Huang JF; Hu BQ; Zhou J; Wang X; Feng ZZ; Chen YT; Pan FM; Cheng HD; Chen LW
World J Surg Oncol; 2022 May; 20(1):159. PubMed ID: 35590371
[TBL] [Abstract] [Full Text] [Related]
[Next]
